Sun Pharma#39;s offer amounts to about $347.8 million, as per Reuters calculations, with the per share value at a 4.2% premium to Taro#39;s close on Wednesday.from Moneycontrol Business News https://ift.tt/eBX9bI5
Wednesday, January 17, 2024
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
In a regulatory filing the company said the Odisha Electricity Regulatory Commission (OERC) has awarded the Letter of Intent (LOI) to Tata ...
-
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
No comments:
Post a Comment